News and Trends 12 Dec 2024 Top biotech deals of November 2024 November has seen a variety of biotech deals take place to advance therapies across different stages in development. December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 6 Dec 2024Cracking the code of biotech valuations Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom. December 6, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 25 Nov 2024 Evotec on the brink of acquisition: At what cost for the biotech industry? As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape. November 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 4 Nov 2024 Top biotech deals of October 2024 Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024. November 4, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2024 Second biotech IPO boom of the year: what does it mean for the industry? Discover why biotech is experiencing a second IPO boom in 2024 and what it means for the broader industry. October 10, 2024 - 9 minutesmins - By Monica Karpinski Share WhatsApp Twitter Linkedin Email
In Depth 8 Oct 2024 Top biotech deals of September 2024 There were a number of deals that stirred the biopharma industry in September. We have listed the major collaborations that took place last month. October 8, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 12 Sep 2024 Biotech R&D crunch: The impact of the Inflation Reduction Act and economic challenges Delve into the consequences of the Inflation Reduction Act and the broader economic conditions on biotech R&D. September 12, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 2 Sep 2024 Are we in an AI bubble? Biotech AI startups’ value plummet and leads to restructuration Delve into the downturn AI is experiencing in biotech: Is the bubble bursting or is the market correcting the high expectations? September 2, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 23 Aug 2024New German biotech spins out to develop radiotherapeutics While it is currently owned by the Eckert & Ziegler Group, Pentixapharm will soon be spun off as a separate company. Listen to our conversation with Andreas Eckert, founder of the company August 23, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 28 Jun 2024 Going nuclear: radiopharmaceuticals funding sees surge in 2024 Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research as biotechs nab major funding deals. June 28, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 26 Jun 2024 Biotech megadeals: Exploring the surge in $100M+ deals Biotech and healtcare contributed to more than one out of three megadeals in 2024, find out the reasons behind it. June 26, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 24 Jun 2024 Troublesome acquisitions: when biotech M&A goes wrong Dive deeper into the world of M&A, as we take a look at some of the most prominent failed acquisitions of the last decade. June 24, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email